Treatment for Marginal Zone Lymphoma: Should it be Different from Follicular Lymphoma?

Описание к видео Treatment for Marginal Zone Lymphoma: Should it be Different from Follicular Lymphoma?

Earn CME for related activities: https://www.naccme.com/oln

In this webcast from the 'Treatment for Marginal Zone Lymphoma: Should it be Different from FL?' symposium during the 2019 Lymphoma & Myeloma conference in New York, Dr. Thomas M. Habermann discusses whether treatment of marginal zone lymphoma (MZL) should be different than that of follicular lymphoma.

© 2019 Imedex, an HMP Company

Комментарии

Информация по комментариям в разработке